Selective Inhibitors of Cyclooxygenase-2 Delay the Activation of Nuclear Factor kappa B and Attenuate the Expression of Inflammatory Genes in Murine Macrophages Treated with Lipopolysaccharide

N. A. Callejas
  • Molecular Pharmacology, March 2003, American Society for Pharmacology & Experimental Therapeutics (ASPET)
  • DOI: 10.1124/mol.63.3.671

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Lisardo Bosca